Truist Financial boosted price target and gave buy rating, and TD Cowen lifted target price and gave buy rating for Encompass Health.
2 reports, 2 independent
Updated Mon 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial boosted price target and gave buy rating, and TD Cowen lifted target price and gave buy rating for Encompass Health.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Encompass Health
American health care company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
TD Cowen
American investment bank
Related events
- Truist Financial and TD Cowen provided rating and price targets for SiBone shares.
- Financial firms including Royal Bank of Canada, Truist Financial, TD Cowen, and Barclays have announced price target increases for Medpace.
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- TD Cowen, Stephens, Citigroup, and MarketBeat provided new analyst ratings and coverage for Covenant Logistics Group, Inc.
- Truist Financial and TD Cowen raised target prices and issued buy ratings for Astrana Health, Inc. on June 10, 2026.